We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments.
The addition of the Clayton site in 2011 marked a new milestone for Grifols, turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The...
Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infections Arboviruses are a growing emerging threat, with changes in...
In the AdFIrst study, Biotest's fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired fibrinogen deficiency (AFD) as equivalent to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2099 | 2.27904451683 | 9.21 | 9.51 | 9.2 | 3699 | 9.32153049 | CS |
4 | 0.0099 | 0.105207226355 | 9.41 | 9.72 | 9.2 | 3606 | 9.3744986 | CS |
12 | 0.4699 | 5.25027932961 | 8.95 | 9.72 | 8.78 | 3495 | 9.28305221 | CS |
26 | 1.1589 | 14.02856797 | 8.261 | 10.19 | 7.93 | 3571 | 9.05113705 | CS |
52 | 1.0949 | 13.151951952 | 8.325 | 10.19 | 7.93 | 3099 | 8.90384367 | CS |
156 | 0.6799 | 7.77917620137 | 8.74 | 11.25 | 7.8 | 4691 | 9.0663711 | CS |
260 | 1.6999 | 22.0194300518 | 7.72 | 11.25 | 5.2 | 5022 | 8.32236255 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions